Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases
US7611705B2 · kind B2 · utility
22Cited by
1References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 15, 2007 |
| Grant date | Nov 3, 2009 |
| Priority date | — |
| Expiry date | Jun 23, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention features an antibody specifically binding to human IL-20 (e.g., mAb 7E and a equivalent thereof) and its use in treating an IL-20 associated inflammatory disease, such as atherosclerosis, RA, psoriasis, psoriatic arthritis, bacteria-induced gastric ulcer, and acute renal failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.